Chapter 1. Research Scope
1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
1.4.1. Market size breakdown, by product type
1.4.2. Market size breakdown, by application
1.4.3. Market size breakdown, by end use
1.4.4. Market size breakdown, by region
1.4.5. Market size breakdown, by country
1.5. Market Data Reporting Unit
1.5.1. Value
1.6. Key Stakeholders
Chapter 2. Research Methodology
2.1. Secondary Research
2.1.1. Paid
2.1.2. Unpaid
2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Voice of Industry Experts/KOLs
Chapter 5. Market Indicators
Chapter 6. Industry Outlook
6.1. Market Dynamics
6.1.1. Trends
6.1.2. Drivers
6.1.3. Restraints/challenges
6.1.4. Impact analysis of drivers/restraints
6.2. Impact of COVID-19
6.3. Porter’s Five Forces Analysis
6.3.1. Bargaining power of buyers
6.3.2. Bargaining power of suppliers
6.3.3. Threat of new entrants
6.3.4. Intensity of rivalry
6.3.5. Threat of substitutes
Chapter 7. Global Market
7.1. Overview
7.2. Market Revenue, by Product Type (2017–2030)
7.3. Market Revenue, by Application (2017–2030)
7.4. Market Revenue, by End Use (2017–2030)
7.5. Market Revenue, by Region (2017–2030)
Chapter 8. North America Market
8.1. Overview
8.2. Market Revenue, by Product Type (2017–2030)
8.3. Market Revenue, by Application (2017–2030)
8.4. Market Revenue, by End Use (2017–2030)
8.5. Market Revenue, by Country (2017–2030)
Chapter 9. Europe Market
9.1. Overview
9.2. Market Revenue, by Product Type (2017–2030)
9.3. Market Revenue, by Application (2017–2030)
9.4. Market Revenue, by End Use (2017–2030)
9.5. Market Revenue, by Country (2017–2030)
Chapter 10. APAC Market
10.1. Overview
10.2. Market Revenue, by Product Type (2017–2030)
10.3. Market Revenue, by Application (2017–2030)
10.4. Market Revenue, by End Use (2017–2030)
10.5. Market Revenue, by Country (2017–2030)
Chapter 11. LATAM Market
11.1. Overview
11.2. Market Revenue, by Product Type (2017–2030)
11.3. Market Revenue, by Application (2017–2030)
11.4. Market Revenue, by End Use (2017–2030)
11.5. Market Revenue, by Country (2017–2030)
Chapter 12. MEA Market
12.1. Overview
12.2. Market Revenue, by Product Type (2017–2030)
12.3. Market Revenue, by Application (2017–2030)
12.4. Market Revenue, by End Use (2017–2030)
12.5. Market Revenue, by Country (2017–2030)
Chapter 13. U.S. Market
13.1. Overview
13.2. Market Revenue, by Product Type (2017–2030)
13.3. Market Revenue, by Application (2017–2030)
13.4. Market Revenue, by End Use (2017–2030)
Chapter 14. Canada Market
14.1. Overview
14.2. Market Revenue, by Product Type (2017–2030)
14.3. Market Revenue, by Application (2017–2030)
14.4. Market Revenue, by End Use (2017–2030)
Chapter 15. Germany Market
15.1. Overview
15.2. Market Revenue, by Product Type (2017–2030)
15.3. Market Revenue, by Application (2017–2030)
15.4. Market Revenue, by End Use (2017–2030)
Chapter 16. France Market
16.1. Overview
16.2. Market Revenue, by Product Type (2017–2030)
16.3. Market Revenue, by Application (2017–2030)
16.4. Market Revenue, by End Use (2017–2030)
Chapter 17. U.K. Market
17.1. Overview
17.2. Market Revenue, by Product Type (2017–2030)
17.3. Market Revenue, by Application (2017–2030)
17.4. Market Revenue, by End Use (2017–2030)
Chapter 18. Italy Market
18.1. Overview
18.2. Market Revenue, by Product Type (2017–2030)
18.3. Market Revenue, by Application (2017–2030)
18.4. Market Revenue, by End Use (2017–2030)
Chapter 19. Spain Market
19.1. Overview
19.2. Market Revenue, by Product Type (2017–2030)
19.3. Market Revenue, by Application (2017–2030)
19.4. Market Revenue, by End Use (2017–2030)
Chapter 20. Japan Market
20.1. Overview
20.2. Market Revenue, by Product Type (2017–2030)
20.3. Market Revenue, by Application (2017–2030)
20.4. Market Revenue, by End Use (2017–2030)
Chapter 21. China Market
21.1. Overview
21.2. Market Revenue, by Product Type (2017–2030)
21.3. Market Revenue, by Application (2017–2030)
21.4. Market Revenue, by End Use (2017–2030)
Chapter 22. India Market
22.1. Overview
22.2. Market Revenue, by Product Type (2017–2030)
22.3. Market Revenue, by Application (2017–2030)
22.4. Market Revenue, by End Use (2017–2030)
Chapter 23. Australia Market
23.1. Overview
23.2. Market Revenue, by Product Type (2017–2030)
23.3. Market Revenue, by Application (2017–2030)
23.4. Market Revenue, by End Use (2017–2030)
Chapter 24. South Korea Market
24.1. Overview
24.2. Market Revenue, by Product Type (2017–2030)
24.3. Market Revenue, by Application (2017–2030)
24.4. Market Revenue, by End Use (2017–2030)
Chapter 25. Brazil Market
25.1. Overview
25.2. Market Revenue, by Product Type (2017–2030)
25.3. Market Revenue, by Application (2017–2030)
25.4. Market Revenue, by End Use (2017–2030)
Chapter 26. Mexico Market
26.1. Overview
26.2. Market Revenue, by Product Type (2017–2030)
26.3. Market Revenue, by Application (2017–2030)
26.4. Market Revenue, by End Use (2017–2030)
Chapter 27. Saudi Arabia Market
27.1. Overview
27.2. Market Revenue, by Product Type (2017–2030)
27.3. Market Revenue, by Application (2017–2030)
27.4. Market Revenue, by End Use (2017–2030)
Chapter 28. South Africa Market
28.1. Overview
28.2. Market Revenue, by Product Type (2017–2030)
28.3. Market Revenue, by Application (2017–2030)
28.4. Market Revenue, by End Use (2017–2030)
Chapter 29. U.A.E. Market
29.1. Overview
29.2. Market Revenue, by Product Type (2017–2030)
29.3. Market Revenue, by Application (2017–2030)
29.4. Market Revenue, by End Use (2017–2030)
Chapter 30. Competitive Landscape
30.1. List of Market Players and their Offerings
30.2. Competitive Benchmarking of Key Players
30.3. Product Benchmarking of Key Players
30.4. Recent Strategic Developments
Chapter 31. Company Profiles
31.1. BASF SE
31.1.1. Business overview
31.1.2. Product and service offerings
31.1.3. Key financial summary
31.2. Koninklijke DSM N.V.
31.2.1. Business overview
31.2.2. Product and service offerings
31.2.3. Key financial summary
31.3. Herbalife Nutrition Ltd.
31.3.1. Business overview
31.3.2. Product and service offerings
31.3.3. Key financial summary
31.4. Amway Corporation
31.4.1. Business overview
31.4.2. Product and service offerings
31.4.3. Key financial summary
31.5. Prenetics Limited
31.5.1. Business overview
31.5.2. Product and service offerings
31.5.3. Key financial summary
31.6. Nutrigenomix Inc.
31.6.1. Business overview
31.6.2. Product and service offerings
31.7. Viome Life Sciences Inc.
31.7.1. Business overview
31.7.2. Product and service offerings
31.8. Habit LLC
31.8.1. Business overview
31.8.2. Product and service offerings
31.9. Atlas Biomed Group Limited
31.9.1. Business overview
31.9.2. Product and service offerings
31.10. Abbott
31.10.1. Business overview
31.10.2. Product and service offerings
31.10.3. Key financial summary
31.11. Superior Supplement Manufacturing
31.11.1. Business overview
31.11.2. Product and service offerings
31.12. GX Sciences LLC
31.12.1. Business overview
31.12.2. Product and service offerings
31.13. Nutralliance
31.13.1. Business overview
31.13.2. Product and service offerings
31.14. Helix OpCo LLC
31.14.1. Business overview
31.14.2. Product and service offerings
31.15. Baze Labs Inc.
31.15.1. Business overview
31.15.2. Product and service offerings
Chapter 32. Appendix
32.1. Abbreviations
32.2. Sources and References
32.3. Related Reports
| ※参考情報 個別化栄養（Personalized Nutrition）とは、人それぞれの生理的特性や遺伝的背景、ライフスタイルに基づいて栄養を最適化するアプローチです。従来の栄養学では、一般的な食事ガイドラインに基づいて栄養を提供することが中心でしたが、個別化栄養は個体差を重視し、よりきめ細やかな栄養管理を目指しています。このアプローチは、健康維持や病気予防、さらには疾病の治療においても重要な役割を果たしています。 個別化栄養の種類はさまざまですが、主なものには遺伝子栄養学、血液栄養、メタボローム解析などがあります。遺伝子栄養学では、個々の遺伝情報を解析して、特定の栄養素に対する必要量や代謝の違いを理解し、それに基づいた食生活を提案します。たとえば、特定の遺伝子変異を持つ人々は、ある栄養素を多く必要とする場合があります。血液栄養では、血液中の栄養素の状態を測定し、個人にジャストフィットな栄養アドバイスを行います。メタボローム解析は、体内の代謝物を解析して、個人の健康状態や食事の影響を評価します。これにより、食事と健康の関係をより深く理解することができ、より効果的な栄養プランが作成されます。 個別化栄養の用途は非常に多岐にわたります。例えば、肥満や糖尿病、高血圧などの生活習慣病に対する予防や治療に効果的です。個人の体質に合わせた食事を提案することで、病気のリスクを軽減し、治療効果を高めることができます。また、スポーツ栄養としても、その選手のパフォーマンス向上を目的にした食事指導が行われています。アスリートに対しては、トレーニングや試合に合わせた栄養戦略が提供され、個々のパフォーマンスを最大化することが期待されます。 関連技術としては、遺伝子検査や血液検査、AIを活用した栄養分析ツールなどがあります。遺伝子検査は、個々の遺伝的特性に基づく食事の最適化を可能にし、受け取ったデータをもとに医療従事者が具体的な指導を行います。血液検査は定期的に行うことで、栄養状態を把握し、必要に応じて食事内容を調整します。AI技術は、食事のレシピ提案や栄養成分の分析だけでなく、個人の健康情報をもとに最適な食事プランを生成することが可能です。 個別化栄養は、今後の健康管理において重要な役割を果たすと考えられています。特に、現代の食生活が多様化する中で、過剰な栄養素摂取や不足といった問題が浮上しています。個別化栄養を取り入れることで、個々の健康状態を把握し、病気の予防や改善につなげることができるでしょう。さらに、個別化された食事指導は、心理的な満足感を高め、継続的な健康管理を促す要因ともなります。 近年の研究や技術の進展により、個別化栄養はますます進化しています。栄養科学の知識が深まる中で、個別化栄養の効果を実証するエビデンスも増加しています。これにより、医療現場や健康支援の分野での導入が加速し、多くの人々が個別化栄養の恩恵を受けられる可能性が広がっています。 今後も個別化栄養は、私たちの健康に直結する重要な分野として注目され続けるでしょう。個人に応じた食事の選択肢が増え、より豊かな生活を送るための一助となることが期待されています。私たちの食生活が一人ひとりの健康にどのように影響を与えるか、理解しながら選んでいくことが求められる時代に突入していると言えます。個別化栄養は、未来の健康を守る鍵となるかもしれません。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
